APA (7th ed.) Citation

M, R., AR, I., A, D., A, T., SM, I. H., A, W., & MFFM, A. (2025). In-silico evaluation of diffractaic acid as novel anti-diabetic inhibitor against dipeptidyl peptidase IV enzyme. In silico pharmacology, 13(1), 24. https://doi.org/10.1007/s40203-025-00321-9

Chicago Style (17th ed.) Citation

M, Roney, Issahaku AR, Dubey A, Tufail A, Istiaque Hamim SM, Wilhelm A, and Aluwi MFFM. "In-silico Evaluation of Diffractaic Acid as Novel Anti-diabetic Inhibitor Against Dipeptidyl Peptidase IV Enzyme." In Silico Pharmacology 13, no. 1 (2025): 24. https://doi.org/10.1007/s40203-025-00321-9.

MLA (9th ed.) Citation

M, Roney, et al. "In-silico Evaluation of Diffractaic Acid as Novel Anti-diabetic Inhibitor Against Dipeptidyl Peptidase IV Enzyme." In Silico Pharmacology, vol. 13, no. 1, 2025, p. 24, https://doi.org/10.1007/s40203-025-00321-9.